English 中文

News Center

您现在的位置：

Li Jie, deputy to the National People's Congress: It is recommended to increase support for innovative drug companies

Information

Li Jie, deputy to the National People's Congress: It is recommended to increase support for innovative drug companies

Categories:Entreprise's news
Author:
Origin:
Time of issue:2020-09-15
Views:0

(Summary description)Beijing News (Reporter Yan Xia) In 2019, the state implemented a series of policies and measures to reduce taxes and fees. The cumulative increase in tax and fee reductions throughout the year exceeded 2 trillion yuan. The tax burdens of all industries have decreased to varying degrees, which effectively stimulated The vitality of market entities has been enhanced and confidence in economic development has been enhanced.

Li Jie, deputy to the National People's Congress: It is recommended to increase support for innovative drug companies

Categories:Entreprise's news
Author:
Origin:
Time of issue:2020-09-15
Views:0

Information

　　Beijing News (Reporter Yan Xia) In 2019, the state implemented a series of policies and measures to reduce taxes and fees. The cumulative increase in tax and fee reductions throughout the year exceeded 2 trillion yuan. The tax burdens of all industries have decreased to varying degrees, which effectively stimulated The vitality of market entities has been enhanced and confidence in economic development has been enhanced.

　　In 2020, the real economy is still facing the challenges of industrial upgrading and structural transformation. How to further reduce the financial pressure of enterprises so that enterprises can better invest their limited funds in R&D and innovation, cultivate innovation vitality, and promote high-quality and sustainable development of enterprises Vital.

　　 Therefore, Li Jie, representative of the National People's Congress and Chairman of Human Welfare Medicine, brought a proposal at the two sessions this year on further optimizing tax and fee policies and encouraging technological innovation in enterprises.

　　 Li Jie hopes that the tax rate can be further reduced. He believes that in the current economic environment, lowering the tax rate is the most direct means of reducing the burden on enterprises. "I hope that the tax rate can be combined with three levels in the later stage and reduce the 13% tax rate applicable to most manufacturing industries."

　　In addition, Li Jie also suggested to reduce the labor cost of enterprises. He explained in detail: “In 2019, the comprehensive plan of Guobanfa [2019] No. 13 to reduce social insurance rates was announced, which will reduce the burden of social insurance payment enterprises to a certain extent. However, in a comprehensive view The labor costs of enterprises are still too high. We hope that the government will continue to reduce the corporate payment rates for social security, employment security payments for the disabled, and labor union funds."

　　 For companies that develop innovative drugs, Li Jie hopes that the government can increase support.

　　 Li Jie said that in 2016, my country’s drug regulatory agency officially proposed the concept of “innovative drugs” for the first time, which was defined as “drugs that have not been marketed in China”, and the scope changed from “Chinese New” to “Global New”. Under the current economic environment, the expansion of traditional pharmaceutical companies has been difficult to inherit, and domestic pharmaceutical companies need to innovate and change. Owning innovative drugs developed independently is the key to the sustainable development of a company. However, the large investment in research and development of innovative drugs, long time, and high failure rate require not only the persistence of enterprises, but also the support of the state.

　　 "We hope that the state can formulate special preferential tax policies for companies that develop innovative drugs." Li Jie said.

Scan the QR code to read on your phone

Previous: Renfu Pharmaceutical Group visited Huawei's Wuhan R&D Center

Next: Hubei Provincial Party Secretary Ying Yong visited Yichang Renfu Pharmaceutical to inspect and supervise the resumption of work and production

Previous: Renfu Pharmaceutical Group visited Huawei's Wuhan R&D Center

Next: Hubei Provincial Party Secretary Ying Yong visited Yichang Renfu Pharmaceutical to inspect and supervise the resumption of work and production

Message

WRITE A MESSAGE TO US

Username used for comment:

Client messages

Description:

Cell phone：